|
1
|
American College6 of Obstetricians and
Gynecologists, . Task Force on Hypertension in Pregnancy:
Hypertension in pregnancy. Report of the American College of
Obstetricians and Gynecologists' Task Force on Hypertension in
Pregnancy. Obstet Gynecol. 122:1122–1131. 2013.PubMed/NCBI
|
|
2
|
Redman CW and Sargent IL: Latest advances
in understanding preeclampsia. Science. 308:1592–1594. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duley L: The global impact of
pre-eclampsia and eclampsia. Semin Perinatol. 33:130–137. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Report of the National High Blood Pressure
Education Program Working Group on High Blood Pressure in
Pregnancy. Am J Obstet Gynecol. 183:S1–S22. 2000. View Article : Google Scholar
|
|
5
|
Sibai B, Dekker G and Kupferminc M:
Pre-eclampsia. Lancet. 365:785–799. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huppertz B: Placental origins of
preeclampsia: Challenging the current hypothesis. Hypertension.
51:970–975. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Foidart JM, Noël A, Chantraine F, Lorquet
S, Petit P, Munaut C, Berndt S, Pequeux C and Schaaps JP: Defective
placental implantation and its effects on maternal endothelial
function. Bull Acad Natl Med. 193:1059–1064; discussion 1064–1066,
1067–1068. 2009.(In French). PubMed/NCBI
|
|
8
|
Foidart JM, Schaaps JP, Chantraine F,
Munaut C and Lorquet S: Dysregulation of anti-angiogenic agents
(sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but
not the definitive answer. J Reprod Immunol. 82:106–111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Redman CW, Sargent IL and Staff AC: IFPA
Senior Award Lecture: Making sense of pre-eclampsia - two placental
causes of preeclampsia? Placenta. 35:S20–S25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Munaut C, Lorquet S, Pequeux C, Blacher S,
Berndt S, Frankenne F and Foidart JM: Hypoxia is responsible for
soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but
not for soluble endoglin induction in villous trophoblast. Hum
Reprod. 23:1407–1415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roberts JM and Hubel CA: The two stage
model of preeclampsia: Variations on the theme. Placenta. 30:(Suppl
A). S32–S37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Redman CW and Sargent IL: Immunology of
pre-eclampsia. Am J Reprod Immunol. 63:534–543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dechend R and Staff AC: Placenta messages
to the mother: Not just debris. Hypertension. 59:191–193. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai EC: Micro RNAs are complementary to 3
UTR sequence motifs that mediate negative post-transcriptional
regulation. Nat Genet. 30:363–364. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ong SG, Lee WH, Kodo K and Wu JC:
MicroRNA-mediated regulation of differentiation and
trans-differentiation in stem cells. Adv Drug Deliv Rev. 88:3–15.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miura K, Miura S, Yamasaki K, Higashijima
A, Kinoshita A, Yoshiura K and Masuzaki H: Identification of
pregnancy-associated microRNAs in maternal plasma. Clin Chem.
56:1767–1771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsochandaridis M, Nasca L, Toga C and
Levy-Mozziconacci A: Circulating microRNAs as clinical biomarkers
in the predictions of pregnancy complications. BioMed Res Int.
2015:2949542015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li H, Ge Q, Guo L and Lu Z: Maternal
plasma miRNAs expression in preeclamptic pregnancies. Biomed Res
Int. 2013:9702652013.PubMed/NCBI
|
|
21
|
Wu L, Zhou H, Lin H, Qi J, Zhu C, Gao Z
and Wang H: Circulating microRNAs are elevated in plasma from
severe preeclamptic pregnancies. Reproduction. 143:389–397. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gunel T, Zeybek YG, Akçakaya P, Kalelioğlu
I, Benian A, Ermis H and Aydınlı K: Serum microRNA expression in
pregnancies with preeclampsia. Genet Mol Res. 10:4034–4040. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ura B, Feriotto G, Monasta L, Bilel S,
Zweyer M and Celeghini C: Potential role of circulating microRNAs
as early markers of preeclampsia. Taiwan J Obstet Gynecol.
53:232–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y,
Guo H, Fei M and Sun S: Plasma microRNA-122 as a biomarker for
viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem.
56:1830–1838. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kok MG, Halliani A, Moerland PD, Meijers
JC, Creemers EE and Pinto-Sietsma SJ: Normalization panels for the
reliable quantification of circulating microRNAs by RT-qPCR. FASEB
J. 29:3853–3862. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanley JA and McNeil BJ: The meaning and
use of the area under a receiver operating characteristic (ROC)
curve. Radiology. 143:29–36. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Z, Moley KH and Gronowski AM:
Diagnostic potential for miRNAs as biomarkers for
pregnancy-specific diseases. Clin Biochem. 46:953–960. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Gelfond JA, McManus LM and
Shireman PK: Reproducibility of quantitative RT-PCR array in miRNA
expression profiling and comparison with microarray analysis. BMC
Genomics. 10:4072009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sato F, Tsuchiya S, Terasawa K and
Tsujimoto G: Intra-platform repeatability and inter-platform
comparability of microRNA microarray technology. PLoS One.
4:e55402009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roberts TC, Coenen-Stass AML and Wood MJA:
Assessment of RT-qPCR normalization strategies for accurate
quantification of extracellular microRNAs in murine serum. PLoS
One. 9:e892372014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Anton L, Olarerin-George AO, Schwartz N,
Srinivas S, Bastek J, Hogenesch JB and Elovitz MA: miR-210 inhibits
trophoblast invasion and is a serum biomarker for preeclampsia. Am
J Pathol. 183:1437–1445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pineles BL, Romero R, Montenegro D, Tarca
AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P,
et al: Distinct subsets of microRNAs are expressed differentially
in the human placentas of patients with preeclampsia. Am J Obstet
Gynecol. 196:261.e1–261.e6. 2007. View Article : Google Scholar
|
|
34
|
Enquobahrie DA, Abetew DF, Sorensen TK,
Willoughby D, Chidambaram K and Williams MA: Placental microRNA
expression in pregnancies complicated by preeclampsia. Am J Obstet
Gynecol. 204:178.e12–178.e21. 2011. View Article : Google Scholar
|
|
35
|
Muralimanoharan S, Maloyan A, Mele J, Guo
C, Myatt LG and Myatt L: miR-210 modulates mitochondrial
respiration in placenta with preeclampsia. Placenta. 33:816–823.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li
L, Xin H and Sun S: Elevated levels of hypoxia-inducible
microRNA-210 in pre-eclampsia: New insights into molecular
mechanisms for the disease. J Cell Mol Med. 16:249–259. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Camps C, Buffa FM, Colella S, Moore J,
Sotiriou C, Sheldon H, Harris AL, Gleadle JM and Ragoussis J:
hsa-miR-210 Is induced by hypoxia and is an independent prognostic
factor in breast cancer. Clin Cancer Res. 14:1340–1348. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fasanaro P, D'Alessandra Y, Di Stefano V,
Melchionna R, Romani S, Pompilio G, Capogrossi MC and Martelli F:
MicroRNA-210 modulates endothelial cell response to hypoxia and
inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol
Chem. 283:15878–15883. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wulfken LM, Moritz R, Ohlmann C,
Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel
G, von Ruecker A, Müller SC, et al: MicroRNAs in renal cell
carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS
One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Grill S, Rusterholz C, Zanetti-Dällenbach
R, Tercanli S, Holzgreve W, Hahn S and Lapaire O: Potential markers
of preeclampsia-a review. Reprod Biol Endocrinol. 7:702009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meads CA, Cnossen JS, Meher S,
Juarez-Garcia A, ter Riet G, Duley L, Roberts TE, Mol BW, van der
Post JA, Leeflang MM, et al: Methods of prediction and prevention
of pre-eclampsia: systematic reviews of accuracy and effectiveness
literature with economic modelling. Health Technol Assess.
12:1–270. 2008. View Article : Google Scholar
|
|
43
|
Zakiyah N, Postma MJ, Baker PN and van
Asselt AD: IMPROvED Consortium: Pre-eclampsia diagnosis and
treatment options: A review of published economic assessments.
Pharmacoeconomics. 33:1069–1082. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Poon LC, Stratieva V, Piras S, Piri S and
Nicolaides KH: Hypertensive disorders in pregnancy: Combined
screening by uterine artery Doppler, blood pressure and serum
PAPP-A at 11–13 weeks. Prenat Diagn. 30:216–223. 2010.PubMed/NCBI
|
|
45
|
Poon LC, Maiz N, Valencia C, Plasencia W
and Nicolaides KH: First-trimester maternal serum
pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound
Obstet Gynecol. 33:23–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Scazzocchio E, Figueras F, Crispi F, Meler
E, Masoller N, Mula R and Gratacos E: Performance of a
first-trimester screening of preeclampsia in a routine care
low-risk setting. Am J Obstet Gynecol. 208:203.e1–203.e10. 2013.
View Article : Google Scholar
|
|
47
|
Park FJ, Leung CH, Poon LC, Williams PF,
Rothwell SJ and Hyett JA: Clinical evaluation of a first trimester
algorithm predicting the risk of hypertensive disease of pregnancy.
Aust N Z J Obstet Gynaecol. 53:532–539. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Akolekar R, Syngelaki A, Poon L, Wright D
and Nicolaides KH: Competing risks model in early screening for
preeclampsia by biophysical and biochemical markers. Fetal Diagn
Ther. 33:8–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Akolekar R, Syngelaki A, Sarquis R, Zvanca
M and Nicolaides KH: Prediction of early, intermediate and late
pre-eclampsia from maternal factors, biophysical and biochemical
markers at 11–13 weeks. Prenat Diagn. 31:66–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Foidart JM, Munaut C, Chantraine F,
Akolekar R and Nicolaides KH: Maternal plasma soluble endoglin at
11–13 weeks' gestation in pre-eclampsia. Ultrasound Obstet Gynecol.
35:680–687. 2010.PubMed/NCBI
|
|
51
|
Kusanovic JP, Romero R, Chaiworapongsa T,
Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS,
Gomez R, et al: A prospective cohort study of the value of maternal
plasma concentrations of angiogenic and anti-angiogenic factors in
early pregnancy and midtrimester in the identification of patients
destined to develop preeclampsia. J Matern Fetal Neonatal Med.
22:1021–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lycoudi A, Mavreli D, Mavrou A,
Papantoniou N and Kolialexi A: miRNAs in pregnancy-related
complications. Expert Rev Mol Diagn. 15:999–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Morales Prieto DM and Markert UR:
MicroRNAs in pregnancy. J Reprod Immunol. 88:106–111. 2011.
View Article : Google Scholar : PubMed/NCBI
|
